Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in APRE — Aprea Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in APRE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$60,044
-$30,852 QoQ
Shares Held
74,869
-37.2% QoQ
Ownership
0.595%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 28 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. APRE ranks #466 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,044 74,869
2026-03-31 $90,896 119,131
2025-12-31 $34,930 40,950
2025-09-30 $65,808 44,616
2025-06-30 $72,900 43,137
2025-03-31 $87,999 43,137
2024-12-31 $140,360 42,663
2024-09-30 $110,184 40,067
2024-06-30 $145,189 35,673
2024-03-31 $135,278 20,221
2023-12-31 $82,123 17,473
2023-09-30 $72,809 17,473
2023-06-30 $74,308 23,590
2022-12-31 $49,554 149,711
2022-09-30 $97,592 150,142
2022-06-30 $112,606 150,142
2022-03-31 $279,264 150,142
2021-12-31 $430,910 150,143
2021-09-30 $1,013,512 198,339
2021-06-30 $509,701 104,447
2021-03-31 $821,849 161,147
2020-12-31 $726,634 147,690
2020-09-30 $3,208,088 133,337
2020-06-30 $4,117,156 106,167
2020-03-31 $3,340,922 96,114